Zobrazeno 1 - 10
of 273
pro vyhledávání: '"NEUROPATHY CIPN"'
Publikováno v:
Jichu yixue yu linchuang, Vol 44, Iss 10, Pp 1394-1399 (2024)
Objective To summarize the characteristics of chemotherapy-induced peripheral neuropathy (CIPN) in children with acute B-lymphoblast leukemia (B-ALL) and to identify the influencing factors and prognosis of CIPN. Methods The clinical data of 60 child
Externí odkaz:
https://doaj.org/article/87e25613537a42619788364609e4a6fe
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse event observed in patients receiving paclitaxel, associated with initial pathological changes in the peripheral nervous system, i.e., distal nerves and dorsal ro
Externí odkaz:
https://doaj.org/article/a16c4cda158a43fa82978a0bfe8c6295
Publikováno v:
Frontiers in Pain Research, Vol 5 (2024)
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect of cancer treatment that significantly impacts patients' quality of life. This study investigated the effects of targeting metabolic pathways on bortezomib-in
Externí odkaz:
https://doaj.org/article/6707336280f14c9281bfb41ab2bf9e6a
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 2, Pp 255-264 (2023)
Chemotherapy-induced peripheral neuropathy (CIPN) is one of chemotherapies’ most often documented side effects. Patients with CIPN experience spontaneous burning, numbness, tingling, and neuropathic pain in their feet and hands. Currently, there is
Externí odkaz:
https://doaj.org/article/403d5aaf5a584ba88719aedddc9f6b1c
Autor:
Tomoyoshi Miyamoto, Risa Domoto, Fumiko Sekiguchi, Riki Kamaguchi, Rika Nishimura, Misato Matsuno, Maho Tsubota, Masanori Fujitani, Shigekatsu Hatanaka, Yuichi Koizumi, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 3, Pp 315-325 (2022)
Oxaliplatin often induces peripheral neuropathy, a dose-limiting adverse reaction, and in rare cases leads to sinusoidal obstruction syndrome. We thus conducted a retrospective cohort study to examine the relationship between oxaliplatin-induced peri
Externí odkaz:
https://doaj.org/article/ae80f6ce76474753aac680a6bbaefe92
Autor:
Chao Lu, Guangliang Li, Dehou Deng, Rongrong Li, Xiaoyu Li, Xukang Feng, Taoping Wu, Xiying Shao, Weiji Chen
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionUtidelone (UTD1) is a new chemotherapeutic drug for recurrent or metastatic breast cancer. However, it usually leads to severe peripheral neuropathy (PN) and causes numbness of the hands and feet and significant pain in patients' life. El
Externí odkaz:
https://doaj.org/article/02fefe9c6fe648f08fd40e07b77d7242
Autor:
Bernardino Clavo, Emma Borrelli
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/fd82b0ecfe904b679daff48e0fb004b6
Autor:
Risa Domoto, Fumiko Sekiguchi, Riki Kamaguchi, Maiko Iemura, Hiroki Yamanishi, Maho Tsubota, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 1, Pp 156-161 (2022)
We examined the role of ATP and high mobility group box 1 (HMGB1) in paclitaxel-induced peripheral neuropathy (PIPN). PIPN in mice was prevented by HMGB1 neutralization, macrophage depletion, and P2X7 or P2X4 blockade. Paclitaxel and ATP synergistica
Externí odkaz:
https://doaj.org/article/5c9863c762b644f49b16ef8614d4b4ff
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Purpose: Treatment of chemotherapy-induced peripheral neuropathy (CIPN) is challenging for clinicians, and many clinical trials and meta-analyses on CIPN are controversial. There are also few comparisons of the efficacy among drugs used to treat CIPN
Externí odkaz:
https://doaj.org/article/ca76fe2d2f944ac08f9b0ecd7c2160f7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.